Skip to Content

HIVID 0.375 (Hivid 0.375 MG)

Generic Name: zalcitabine

Pill with imprint HIVID 0.375 is Pink, Elliptical / Oval and has been identified as Hivid 0.375 MG. It is supplied by Roche Laboratories.

Hivid is used in the treatment of hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Hivid 0.375 MG is not a controlled substance under the Controlled Substance Act (CSA).

Images for HIVID 0.375

Hivid

Generic Name:
zalcitabine
Imprint:
HIVID 0.375
Strength:
0.375 MG
Color:
Pink
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Roche Laboratories
National Drug Code (NDC):
00004-0220

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide